OR WAIT null SECS
October 27, 2015
According to a third-quarter earnings report, Pfizer’s vaccine business contributed nearly 14% to its total revenue.
October 23, 2015
Univercells will integrate its single-use bioprocess with the Takeda vaccines production platform to allow local production.
October 06, 2015
The PDA report discusses qualification and operational handling of passive thermal protection systems.
October 02, 2015
Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss performing investigations of biological products.
Despite emergence of biologics, small-molecule APIs benefit from industry growth.
September 25, 2015
There is growing interest in the development of liquid formulations in prefilled syringes and autoinjectors, which offer convenience and ease of administration in a home setting.
September 02, 2015
Industry Expert Q&A with Robin M. Silva, Partner, Morgan, Lewis, and Bockius LLP
August 28, 2015
The Pre-Connect Congress will explore pharma industry trends, such as mergers and acquisitions, the biologics market outlook, and innovation in drug delivery among others.
Growth is said to be driven by the deeper penetration of biosimilars in developed and emerging markets as a result of clearer regulatory pathways.
August 13, 2015
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.